Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABRAFENIB Cause Blood lactate dehydrogenase increased? 121 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 121 reports of Blood lactate dehydrogenase increased have been filed in association with DABRAFENIB (Tafinlar). This represents 0.6% of all adverse event reports for DABRAFENIB.

121
Reports of Blood lactate dehydrogenase increased with DABRAFENIB
0.6%
of all DABRAFENIB reports
26
Deaths
59
Hospitalizations

How Dangerous Is Blood lactate dehydrogenase increased From DABRAFENIB?

Of the 121 reports, 26 (21.5%) resulted in death, 59 (48.8%) required hospitalization, and 8 (6.6%) were considered life-threatening.

Is Blood lactate dehydrogenase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 121 reports have been filed with the FAERS database.

What Other Side Effects Does DABRAFENIB Cause?

Pyrexia (3,788) Death (2,740) Malignant neoplasm progression (1,667) Fatigue (1,328) Nausea (1,300) Chills (1,235) Rash (1,078) Vomiting (907) Diarrhoea (901) Headache (697)

What Other Drugs Cause Blood lactate dehydrogenase increased?

ECULIZUMAB (1,290) RITUXIMAB (929) CYCLOPHOSPHAMIDE (843) VINCRISTINE (669) DOXORUBICIN (667) PREDNISONE (636) BENDAMUSTINE (484) DEXAMETHASONE (469) CYTARABINE (389) METHOTREXATE (386)

Which DABRAFENIB Alternatives Have Lower Blood lactate dehydrogenase increased Risk?

DABRAFENIB vs DABRAFENIB\TRAMETINIB DABRAFENIB vs DACARBAZINE DABRAFENIB vs DACLATASVIR DABRAFENIB vs DACLIZUMAB DABRAFENIB vs DACOMITINIB

Related Pages

DABRAFENIB Full Profile All Blood lactate dehydrogenase increased Reports All Drugs Causing Blood lactate dehydrogenase increased DABRAFENIB Demographics